Moskatel LS, Slusky DJG. The state of insurance coverage of calcitonin gene-related peptide-targeted
medications and its impact on the implementation of the American Headache
Society's 2024 consensus statement: An interrupted time-series analysis. Headache 2026;66:801-812.
PMID: 40719064
|